wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26770678-9AE791A3-28F2-4C5F-A3B7-E505CBF08816
Q26770678-9AE791A3-28F2-4C5F-A3B7-E505CBF08816
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26770678-9AE791A3-28F2-4C5F-A3B7-E505CBF08816
VEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedside
P2860
Q26770678-9AE791A3-28F2-4C5F-A3B7-E505CBF08816
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26770678-9AE791A3-28F2-4C5F-A3B7-E505CBF08816
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5ac17bc86b5ff75afbfcfe3b36b447faeafe14ef
P2860
Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (ZODIAC): a double-blind, randomised, phase 3 trial.